These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16987985)

  • 1. Crystal structure of the West Nile virus envelope glycoprotein.
    Nybakken GE; Nelson CA; Chen BR; Diamond MS; Fremont DH
    J Virol; 2006 Dec; 80(23):11467-74. PubMed ID: 16987985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.
    Kanai R; Kar K; Anthony K; Gould LH; Ledizet M; Fikrig E; Marasco WA; Koski RA; Modis Y
    J Virol; 2006 Nov; 80(22):11000-8. PubMed ID: 16943291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential conformational rearrangements in flavivirus membrane fusion.
    Chao LH; Klein DE; Schmidt AG; Peña JM; Harrison SC
    Elife; 2014 Dec; 3():e04389. PubMed ID: 25479384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.
    Hanna SL; Pierson TC; Sanchez MD; Ahmed AA; Murtadha MM; Doms RW
    J Virol; 2005 Nov; 79(21):13262-74. PubMed ID: 16227249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM; Garry RF; Michael SF
    Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
    Oliphant T; Nybakken GE; Engle M; Xu Q; Nelson CA; Sukupolvi-Petty S; Marri A; Lachmi BE; Olshevsky U; Fremont DH; Pierson TC; Diamond MS
    J Virol; 2006 Dec; 80(24):12149-59. PubMed ID: 17035317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.
    Davis CW; Nguyen HY; Hanna SL; Sánchez MD; Doms RW; Pierson TC
    J Virol; 2006 Feb; 80(3):1290-301. PubMed ID: 16415006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A West Nile virus mutant with increased resistance to acid-induced inactivation.
    Martín-Acebes MA; Saiz JC
    J Gen Virol; 2011 Apr; 92(Pt 4):831-40. PubMed ID: 21228127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
    Pierson TC; Sánchez MD; Puffer BA; Ahmed AA; Geiss BJ; Valentine LE; Altamura LA; Diamond MS; Doms RW
    Virology; 2006 Mar; 346(1):53-65. PubMed ID: 16325883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
    Hershkovitz O; Rosental B; Rosenberg LA; Navarro-Sanchez ME; Jivov S; Zilka A; Gershoni-Yahalom O; Brient-Litzler E; Bedouelle H; Ho JW; Campbell KS; Rager-Zisman B; Despres P; Porgador A
    J Immunol; 2009 Aug; 183(4):2610-21. PubMed ID: 19635919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay.
    Rebollo B; Pérez T; Camuñas A; Pérez-Ramírez E; Llorente F; Sánchez-Seco MP; Jiménez-Clavero MÁ; Venteo Á
    J Virol Methods; 2018 Oct; 260():41-44. PubMed ID: 29958922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the Japanese encephalitis virus envelope protein.
    Luca VC; AbiMansour J; Nelson CA; Fremont DH
    J Virol; 2012 Feb; 86(4):2337-46. PubMed ID: 22156523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.
    Plante JA; Torres M; Huang CY; Beasley DWC
    Virology; 2016 Sep; 496():97-105. PubMed ID: 27284640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of epitope-specific neutralizing antibodies against West Nile virus.
    Oliphant T; Nybakken GE; Austin SK; Xu Q; Bramson J; Loeb M; Throsby M; Fremont DH; Pierson TC; Diamond MS
    J Virol; 2007 Nov; 81(21):11828-39. PubMed ID: 17715236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.
    Takahashi H; Ohtaki N; Maeda-Sato M; Tanaka M; Tanaka K; Sawa H; Ishikawa T; Takamizawa A; Takasaki T; Hasegawa H; Sata T; Hall WW; Kurata T; Kojima A
    Microbes Infect; 2009 Nov; 11(13):1019-28. PubMed ID: 19647801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.